Vascular endothelial growth factor exression in uterine cervical cancer: Correlation with clinicopathologic characteristics and survival

Experimental Oncology

Volumn 31, Issue 3, 2009, Pages 179-181

  Goncharuk, I V ^a   Vorobjova, L I ^a   Lukyanova, N Y ^b   Chekhun, V F ^b  

^a NATIONAL CANCER INSTITUTE   (Ukraine)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Human cervical cancer; Immunohistochemistry; Survival; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE INTERVAL; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PELVIS LYMPH NODE; RETROSPECTIVE STUDY; TUMOR CELL; UTERINE CERVIX CANCER;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 72449152723     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fedorenko ZP, Gulak LO, Horokh EL, et al. Cancer in Ukraine, 2006-2007. Bulletin of National cancer-register of Ukraine, Kyiv, 2008; 9: 100 p.
2. Novak OE, Lisnyak IO, Chekhun VF. Angiogenesis in malignant tumour growth: theoretical and practical aspects. Oncology 2002; 4: 244-251 (In Russian).
3. Prozorovskij VB. Blood vessels and cancer. Science and Life 2006; 9: 9-14.
4. Lukyanova NU, Yurchenko OV, Svintsitskiy VS, et al. Prognostic molecular markers at patients with ovarian cancer. Oncology 2006; 8: 241-244 (In Russian).
5. Veldt AM, Hooft L, Diest P, et al. Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence. Eur J Nuclear Med Mol Imaging 2006; 33: 1408-1416 (Pubitemid 44885406)
6. Nesina IP, Romanenko OV, Grinkevich VM, et al. Prognostic meaning of the micro vessels compactness at serious Aden carcinoma of ovarian. Oncology 2008; 10: 238-241 (In Russian).
7. Birner P, Schindl M, Obermair A, et al. Lymphatic microvessel density, as a novel prognosis factor in early-stage invasive cervical cancer. Int J Cancer 2001; 95: 29-33.
8. Brewer CA, Setterdahl JJ, Li MJ, et al. Endoglin expression as a measure of microvessel density in cervical cancer. Obstet Gynecol 2000; 96: 224-228
9. Ferrnandina G, Raneletti FO, Larocca LM, et al. Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer. Clin Cancer Res 2001; 7: 2656-2661
10. Gerald L, Bremer MD, Anton TMG, et al. Tumor angiogenesis: an independent prognosis parameter in cervical cancer. Am J Obstet Gynecol 1996; 174: 126-131
11. Obermair A, Wanner C, Bilgi S, et al. Tumor angiogenesis in stage IB Cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol 1998; 178: 314-319 (Pubitemid 28124133)
12. Vieira SC, Zeferino LC, Bordes da Silva B, et al. Quantification of angiogenesis in cervical cancer: a comparison among three endotelian cell markers. Gynecol Oncol 2004; 93: 121-124
13. Lee IJ, Park KR, Lee KK, et al. Prognostic value of vascular endothelial growth factor in stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2002; 54: 768-779
14. Chin KF, Greenman J, Gardiner E, et al. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant after curative resection in colorectal cancer. Br J Cancer 2000; 83: 1425-1431
15. Seo Y, Baba H, Fukuda T, et al. High expression of vascular endothelial growth factor is associated with liver metastasis and poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000; 88: 2239-2245 (Pubitemid 30247122)
16. Fine B, Valente P, Feinstein GI, et al. VEGF, flt-1, and KDR/flk-1 prognostic indicators in endometrial carcinoma. Gynecol Oncol 2000; 76: 33-39 (Pubitemid 30048316)
17. Lisnyak IO, Alistratov OV, Vinnitska AB, et al. The connection of growth factor of endothelium cells with widespread malignant process at patients with cancer of body and cervical. Oncology 2002; 4: 188-190 (In Russian).
18. Loncaster JA, Cooper RA, Logue JP, et al. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer 2000; 83: 620-625 (Pubitemid 30636303)
19. Bubnovska LM, Kovelska AV, Boldeskul IE, et al. Hypoxia level in gastric cancer and disease outcome. Oncology 2009; 11: 39-44 (In Ukrainian).
20. Mamedova LT. Prognostic factors and the distant results of cervical cancer treatment. Bull NN Blochin Russ Oncol Sci Center 2002; 3: 47-52 (In Russian).
21. Eralp Y, Saip P, Sakar B, et al. Prognostic factors and survival in patients with metastasis or recurrent carcinoma of the cervix. Int J Gynecol Cancer 2003; 13: 497-504. (Pubitemid 38220668)
22. Hellberg D, Tot T, Stendahl U. Pitfalls in immunohistochemical validation of tumour marker expression - Exemplified in invasive cancer of the uterine cervix. Gynecol Oncol 2009; 112: 33-39
23. Tjalma W, Weyler B, Weyn B, et al. The association between vascular endothelial growth factor, microvessel density and clinicopatological features in invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 2000; 92: 251-257
24. Takumo K, Kodama J, Seki N, et al. Different angiogenic pathways in human cervical cancer. Gynecol Oncol 1998; 68: 38-44. (Pubitemid 28109821)